{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:19:00Z","timestamp":1769087940834,"version":"3.49.0"},"reference-count":97,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"DOI":"10.5334\/gh.1124","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:10:37Z","timestamp":1654686637000},"page":"37","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis"],"prefix":"10.5334","volume":"17","author":[{"given":"A.","family":"Marz\u00e0-Florensa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Drotos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gulayin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Irazola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Klipstein-Grobusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vaartjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"key20220608071020_B1","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Compare [Internet]. GBD Compare Data Visualization; 201AD. http:\/\/www.healthdata.org\/gbd\/2019 (accessed 9 June 2021)."},{"issue":"88","key":"key20220608071020_B2","article-title":"Use of medicines recommended for secondary prevention of acute coronary syndrome","volume":"49","year":"2015","journal-title":"Rev Sa\u00fade P\u00fabilca"},{"issue":"3","key":"key20220608071020_B3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5935\/abc.20130062","article-title":"Special Article Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study","volume":"100","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20220608071020_B4","first-page":"1","article-title":"Long-term secondary prevention of acute myocardial infarction (SEPAT) \u2013 guidelines adherence and outcome","volume":"16","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"key20220608071020_B5","first-page":"1","article-title":"South american guidelines for cardiovascular disease prevention and rehabilitation","volume":"103","year":"2014","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"key20220608071020_B6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries","volume":"35","year":"2010","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"key20220608071020_B7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","article-title":"Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease","volume":"10","year":"2015","journal-title":"Glob Heart"},{"issue":"9798","key":"key20220608071020_B8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey","volume":"378","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"key20220608071020_B9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients","volume":"125","year":"2012","journal-title":"AJM"},{"issue":"9667","key":"key20220608071020_B10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries","volume":"373","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"key20220608071020_B11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2013.09.053","article-title":"Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: Insights from the NCDR (National Cardiovascular Data Registry)","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20220608071020_B12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gheart.2016.06.001","article-title":"Secondary CV Prevention in South America in a Community Setting: The PURE Study","volume":"12","year":"2017","journal-title":"Glob Heart"},{"key":"key20220608071020_B13","first-page":"1","article-title":"Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995\u20132015: A systematic review and meta-analysis","year":"2017","journal-title":"PLoS ONE"},{"issue":"11","key":"key20220608071020_B14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/2047487316647827","article-title":"Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries","volume":"23","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"key20220608071020_B15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key20220608071020_B16","article-title":"Rayyan \u2014 a web and mobile app for systematic reviews","year":"2016","journal-title":"Systematic Reviews"},{"issue":"2","key":"key20220608071020_B17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"issue":"2","key":"key20220608071020_B18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.diabres.2012.05.010","article-title":"Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: A systematic review","volume":"98","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"key20220608071020_B19","author":"RStudio Team","year":"2016"},{"issue":"3","key":"key20220608071020_B20","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","year":"2010","journal-title":"J Stat Softw"},{"issue":"6","key":"key20220608071020_B21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.6061\/clinics\/2014(06)07","article-title":"Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary ather-osclerosis","volume":"69","year":"2014","journal-title":"Clinics"},{"issue":"5","key":"key20220608071020_B22","first-page":"275","article-title":"Effect of Diuretic Therapy on Exercise Capacity in Patients With Chronic Angina and Preserved Left Ventricular Function","volume":"49","year":"2007"},{"issue":"10","key":"key20220608071020_B23","article-title":"The Medicine, Angioplasty, or Surgery Study (MASS-II): A Randomized, Controlled Clinical Trial of Three Therapeutic Strategies for Multivessel Coronary Artery Disease","volume":"43","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20220608071020_B24","first-page":"730","article-title":"Life-habit intervention in a public institution","volume":"94","year":"2010","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20220608071020_B25","first-page":"21","article-title":"Association of anemia with clinical outcomes in stable coronary artery disease","volume":"19","year":"2005","journal-title":"Pathophysiol Nat Hist"},{"issue":"5","key":"key20220608071020_B26","first-page":"346","article-title":"Original Article Impact of Chronic Kidney Disease on the Efficacy of Drug-Eluting Stent: Long-term Follow-up Study","volume":"96","year":"2011","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"key20220608071020_B27","first-page":"221","article-title":"Original Article High On-Treatment Platelet Reactivity Predicts Cardiac Events in Patients with Drug-Eluting Stents","volume":"100","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"key20220608071020_B28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2011.01.062","article-title":"Pleiotropic effects of ezetimibe\/simvastatin vs. high dose simvastatin","volume":"158","year":"2012","journal-title":"Int J Cardiol"},{"issue":"5","key":"key20220608071020_B29","first-page":"363","article-title":"Resist\u00eancia ao AAS na doen\u00e7a coronariana est\u00e1vel","volume":"28","year":"2015","journal-title":"Int j Cardiovasc Sci"},{"key":"key20220608071020_B30","first-page":"1","article-title":"P-wave duration is a predictor for long-term mortality in post-CABG patients","year":"2018"},{"issue":"2","key":"key20220608071020_B31","first-page":"204","article-title":"Effect of ventral cardiac denervation in the incidence of atrial fibrilation after coronary artery bypass graft surgery","volume":"23","year":"2008"},{"issue":"4","key":"key20220608071020_B32","first-page":"237","article-title":"Desfechos cl\u00ednicos dos pacientes submetidos \u00e0 interven\u00e7\u00e3o coron\u00e1ria percut\u00e2nea com stent bioabsorv\u00edvel eluidor de everolimus","volume":"51","year":"2018","journal-title":"Medicina (B Aires)"},{"issue":"5","key":"key20220608071020_B33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1474515113505396","article-title":"Lifestyle interventions reduce cardiovascular risk in patients with coronary artery disease: A randomized clinical trial","volume":"13","year":"2014","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"3","key":"key20220608071020_B34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1590\/S1679-45082013000300015","article-title":"Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry","volume":"11","year":"2013","journal-title":"Einstein (Sao Paulo)"},{"issue":"2","key":"key20220608071020_B35","first-page":"111","article-title":"Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica em pacientes com doen\u00e7a coronariana de uma \u00e1rea do nordeste do Brazil","volume":"52","year":"2015","journal-title":"Arq Gastroenterol"},{"issue":"6","key":"key20220608071020_B36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ahj.2015.01.017","article-title":"Tai Chi Chuan improves functional capacity after myocardial infarction: A randomized clinical trial","volume":"169","year":"2015","journal-title":"Am Heart J"},{"key":"key20220608071020_B37","article-title":"Satisfaction with medication in coronary disease treatment: Psychometrics of the Treatment Satisfaction Questionnaire for Medication","volume":"24","year":"2016","journal-title":"Rev Latino-Am Enfermagen"},{"issue":"1","key":"key20220608071020_B38","first-page":"6","article-title":"Clinical Outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT)","volume":"100","year":"2012","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"key20220608071020_B39","first-page":"895","article-title":"Randomized controlled trial of an educational programme to improve self-care in Brazilian patients following percutaneous coronary intervention","year":"2014","journal-title":"John Wiley Sons Ltd"},{"issue":"1","key":"key20220608071020_B40","first-page":"42","article-title":"Readmission of patients with acute coronary syndrome and determinants","volume":"113","year":"2019","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20220608071020_B41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/1516-3180.2018.040940119","article-title":"Left lateral intercostal region versus subxiphoid position for pleural drain during elective coronary artery bypass graft surgery: Randomized clinical trial","volume":"137","year":"2019","journal-title":"Sao Paulo Med J"},{"key":"key20220608071020_B42","article-title":"Maintenance of Gains, Morbidity, and Mortality at 1 Year Following Cardiac Rehabilitation in a Middle-Income Country: A Wait-List Control Crossover Trial","volume":"8","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"key20220608071020_B43","first-page":"65","article-title":"Cardiovascular Rehabilitation of Patients With Ischemic Heart Disease Undergoing Medical Treatment, Percutaneous Transluminal Coronary Angioplasty, and Coronary Artery Bypass Grafting","volume":"88","year":"2006","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"key20220608071020_B44","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1378\/chest.14-2152","article-title":"Impact of OSA on cardiovascular events after coronary artery bypass surgery","volume":"147","year":"2015","journal-title":"Chest"},{"issue":"6","key":"key20220608071020_B45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1590\/S0100-879X2010007500051","article-title":"Predictors of restenosis after percutaneous coronary intervention using bare-metal stents. A comparison between patients with and without dysglycemia Predictors of restenosis after percutaneous coronary intervention using bare-metal stents. A comparison","volume":"43","year":"2010","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"key20220608071020_B46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/13548500903111814","article-title":"World Health Organization quality of life instrument-brief and Short Form-36 in patients with coronary artery disease: Do they measure similar quality of life concepts?","volume":"14","year":"2009","journal-title":"Psychol Heal Med"},{"key":"key20220608071020_B47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/HCR.0000000000000144","article-title":"Continuous Positive Airway Pressure During Exercise Improves Walking Time in Patients Undergoing Inpatient Cardiac Rehabilitation After Coronary Artery Bypass Graft Surgery","volume":"36","year":"2016","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"3","key":"key20220608071020_B48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/1516-3180.2018.0531140319","article-title":"Secondary prevention of coronary heart disease: A cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"137","year":"2019","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"key20220608071020_B49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1753944714531066","article-title":"Influence of typical angina versus inducible myocardial ischemia in the contemporary management of stable coronary artery disease","volume":"8","year":"2014","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"3","key":"key20220608071020_B50","first-page":"316","article-title":"Incidence of postoperative atrial fibrillation in patients undergoing on-pump and off-pump coronary artery bypass grafting","volume":"30","year":"2015","journal-title":"Braz J Cardiovasc Srug"},{"issue":"24","key":"key20220608071020_B51","first-page":"1","article-title":"Preoperative carbohydrate load and intraoperatively infused omega-3 polyunsaturated fatty acids positively impact nosocomial morbidity after coronary artery bypass grafting: A double- blind controlled randomized trial","volume":"16","year":"2017","journal-title":"Nutr J"},{"issue":"3","key":"key20220608071020_B52","article-title":"Relationship between functional class and left ventricular ejection fraction in patients with coronary heart disease candidates for cardiac rehabilitation","volume":"27","year":"2017","journal-title":"Sci Med"},{"issue":"April 2017","key":"key20220608071020_B53","first-page":"E1","article-title":"Validity of the Incremental Shuttle Walk Test to Assess Exercise Safety When Initiating Cardiac Rehabilitation in Low-Resource Settings","volume":"99","year":"2019","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"key20220608071020_B54","first-page":"705","article-title":"Original Article Long-Term Analysis in Acute Coronary Syndrome: Are there any Differences in Morbidity and Mortality?","year":"2010"},{"key":"key20220608071020_B55","first-page":"290","article-title":"Original Article Impact of Stenting and Oral Sirolimus on Endothelium-Dependent and Independent Coronary Vasomotion","year":"2011","journal-title":"Arquivos brasileiros de cardiologia"},{"key":"key20220608071020_B56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1590\/S0100-879X2009000300008","article-title":"Exercise may cause myocardial ischemia at the anaerobic threshold in cardiac rehabilitation programs","volume":"42","year":"2009","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"4","key":"key20220608071020_B57","first-page":"357","article-title":"Stents Farmacol\u00f3gicos Liberadores de Everolimus XienceTM V no Tratamento de Pacientes com Les\u00f5es Coron\u00e1rias Complexas na Pr\u00e1tica Di\u00e1ria: Resultados Iniciais do Registro Brasileiro BRAVO","volume":"19","year":"2011","journal-title":"Rev Bras Cardiol Invasiva"},{"issue":"2","key":"key20220608071020_B58","first-page":"231","article-title":"Six-minute walk test as a tool for assessing the quality of life in patients undergoing coronary artery bypass grafting surgery","volume":"27","year":"2012","journal-title":"Revista Brasileira de Cirurgia Cardiovascular"},{"key":"key20220608071020_B59","first-page":"99","article-title":"Adherencia a la prevenci\u00f3n secundaria de la enfermedad coronaria","volume":"74","year":"2014","journal-title":"Med (Buenos Aires)"},{"issue":"1","key":"key20220608071020_B60","article-title":"Registro prospectivo de tratamiento antitromb\u00f3tico en s\u00edndromes coronarios agudos (EPICOR) Prospective Registry of Antithrombotic Therapy in Acute Coronary Syndromes (EPICOR)","volume":"87","year":"2019","journal-title":"Rev Argent Cardiol"},{"issue":"2","key":"key20220608071020_B61","first-page":"104","article-title":"Elegibilidad para la indicaci\u00f3n de inhibidores de PCSK9 seg\u00fan las recomendaciones de diferentes sociedades cient\u00edficas","volume":"79","year":"2019","journal-title":"Med"},{"issue":"1","key":"key20220608071020_B62","first-page":"11","article-title":"Angioplastia primaria en diab\u00e9ticos vs. no diab\u00e9ticos con infarto agudo de miocardio: predictores de mortalidad","volume":"86","year":"2016","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"key20220608071020_B63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study One-year follow-up","volume":"25","year":"2004","journal-title":"Eur Heart J"},{"issue":"1","key":"key20220608071020_B64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7775\/rac.v86.i1.11430","article-title":"Use of high-intensity statin strategy. Are the guidelines followed?","volume":"86","year":"2018","journal-title":"Rev Argent Cardiol"},{"key":"key20220608071020_B65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4067\/S0034-98872011000100003","article-title":"Resultados chilenos del registro intenacional de factores de riesgo y tratamiento de angina inestable e infarto al miocardio sin supradesnivel del segmento ST: ACCORD (ACcute CORonary syndrome Descriptive study)","volume":"139","year":"2011","journal-title":"Rev Med Chile"},{"key":"key20220608071020_B66","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4067\/S0034-98872013000800003","article-title":"Prevenci\u00f3n secundaria post infarto agudo de miocardio en hospitales p\u00fablicos: implementaci\u00f3n y resultados de las garant\u00edas GES","volume":"141","year":"2013","journal-title":"Rev Med Chile"},{"key":"key20220608071020_B67","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4067\/S0034-98872013000700006","article-title":"Logro de metas de prevenci\u00f3n secundaria, prescripci\u00f3n farmacol\u00f3gica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria","volume":"141","year":"2013","journal-title":"Rev Med Chile"},{"key":"key20220608071020_B68","first-page":"211","article-title":"(TTA)n Polymorphism in 3-Hydroxy-3-Methylglutaryl-Coenzyme A and Response to Atorvastatin in Coronary Artery Disease Patients","volume":"104","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"key20220608071020_B69","article-title":"Angioplasty with stent vs. coronary artery bypass grafting in multivessel disease (ACIRE)","volume":"16","year":"2009","journal-title":"Colomb J Cardiol"},{"issue":"1","key":"key20220608071020_B70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2010.08.035","article-title":"Comparison of Adverse Cardiovascular Events and Bleeding Complications of Loading Dose of Clopidogrel 300 mg Versus 600 mg in Stable Patients Undergoing Elective Percutaneous Intervention (from the CADICE Study)","volume":"107","year":"2011","journal-title":"AJC"},{"issue":"1","key":"key20220608071020_B71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2008.09.005","article-title":"The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors","volume":"139","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20220608071020_B72","first-page":"13","article-title":"Resistencia al \u00e1cido acetil salic\u00edlico en pacientes con enfermedad coronaria","volume":"13","year":"2006","journal-title":"Rev Colomb Cardiol"},{"issue":"2","key":"key20220608071020_B73","first-page":"59","article-title":"Prevenci\u00f3n secundaria en pacientes revascularizados coronarios en Uruguay: descripci\u00f3n de un programa, evaluaci\u00f3n del control de los factores de riesgo y efecto en la mortalidad","volume":"22","year":"2010","journal-title":"Clin Invest Ateriosc"},{"issue":"1","key":"key20220608071020_B74","first-page":"47","article-title":"CABG and preoperative use of beta-blockers in patients with stable angina are associated with better cardiovascular survival","volume":"33","year":"2018","journal-title":"Brazilian J Cardiovasc Surg"},{"key":"key20220608071020_B75","first-page":"108","article-title":"Control del riesgo cardiovascular postinternaci\u00f3n en pacientes coronarios","volume":"26","year":"2011","journal-title":"Rev Urug Cardiol"},{"issue":"9","key":"key20220608071020_B76","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/03007995.2020.1793313","article-title":"Profile of use and access to statins in patients with coronary arterial disease in an outpatient clinic of a teaching hospital","volume":"36","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"key20220608071020_B77","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)","volume":"83","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"3","key":"key20220608071020_B78","first-page":"230","article-title":"Elevated High-Sensitivity Troponin I in the Stabilized Phase after an Acute Coronary Syndrome Predicts All-Cause and Cardiovascular Mortality in a Highly Admixed Population: A 7-Year Cohort","volume":"112","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"key20220608071020_B79","first-page":"559","article-title":"Underuse of American College of Cardiology\/American Heart Association Guidelines in Hemodialysis Patients Underuse of American College of Cardiology\/American Heart Association Guidelines in Hemodialysis Patients","volume":"29","year":"2009","journal-title":"Ren Fail"},{"key":"key20220608071020_B80","first-page":"238","article-title":"Cardiovascular prevention in coronary heart disease patients: Guidelines implementation in clinical practice","year":"2013","journal-title":"Revista Brasileira de Cirurgia Cardiovascular"},{"issue":"6","key":"key20220608071020_B81","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1590\/S0102-311X2012000600011","article-title":"Utiliza\u00e7\u00e3o de \u00e1cido acetilsalic\u00edlico (AAS) na preven\u00e7\u00e3o de doen\u00e7as cardiovasculares: um estudo de base populacional Aspirin use in cardiovascular disease prevention: a population-based study","volume":"28","year":"2012","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"key20220608071020_B82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2019.09.015","article-title":"Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry","volume":"300","year":"2020","journal-title":"Int J Cardiol"},{"issue":"7","key":"key20220608071020_B83","first-page":"1133","article-title":"Why are clinical practice guidelines not followed? The European Federation of Clinical Chemistry and Laboratory Medicine and European Union of Medical Specialists joint working group on Guidelines","volume":"54","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"key20220608071020_B84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","article-title":"Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999\u20132013","volume":"12","year":"2017","journal-title":"Glob Heart"},{"issue":"4","key":"key20220608071020_B85","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/2047487316676906","article-title":"Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004\u20132013 Europe","volume":"24","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"key20220608071020_B86","first-page":"7","article-title":"Consenso SAC 2001","year":"1981"},{"key":"key20220608071020_B87","article-title":"Diretrizes SBC 2004\u20132008","author":"Sociedade Brasileira de Cardiologia"},{"key":"key20220608071020_B88","author":"Sociedade Brasileira de Cardiologia"},{"key":"key20220608071020_B89","article-title":"Diretrizes SBC 2007\u20132011","author":"Sociedade Brasileira de Cardiologia","year":"2011"},{"key":"key20220608071020_B90","first-page":"728","article-title":"Diretrizes da SBC 2009\u20132014","author":"Sociedade Brasileira de Cardiologia","year":"2014","journal-title":"Soc Bras Cardiol"},{"key":"key20220608071020_B91","first-page":"1","article-title":"Diretrizes da Sociedade Brasileira de Cardiologia: Pocket Book 2013\u20132015","volume":"7","year":"2015","journal-title":"Soc Bras Cardiol"},{"issue":"2","key":"key20220608071020_B92","article-title":"Consenso Prevenci\u00f3n Cardiovascular","volume":"80","year":"2012","journal-title":"Rev Argent Cardiol"},{"issue":"7810","key":"key20220608071020_B93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","year":"2020","journal-title":"Nature"},{"issue":"41","key":"key20220608071020_B94","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/eurheartj\/eht368","article-title":"Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998\u20132010","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"key20220608071020_B95","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/jwh.2012.3972","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","year":"2014","journal-title":"J Women\u2019s Heal"},{"key":"key20220608071020_B96","doi-asserted-by":"crossref","first-page":"101342","DOI":"10.1016\/j.pmedr.2021.101342","article-title":"Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study","volume":"22","year":"2021","journal-title":"Prev Med Reports"},{"key":"key20220608071020_B97","article-title":"Women Are Less Likely to Get Secondary Prevention Medications and Cardiac Rehabilitation. Clinical Topics","year":"2017","journal-title":"American College of Cardiology"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/doi.org\/10.5334\/gh.1124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:22:35Z","timestamp":1657531355000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.5334\/gh.1124\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.5334\/gh.1124","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,8]]}}}